Rizatriptan Benzoate Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 18 pharmaceutical companies such as GLENMARK PHARMS LTD, TEVA PHARMS, SANDOZ and others. It is marketed under 3 brand names, including RIZATRIPTAN BENZOATE, RIZAFILM, SYMBRAVO. Available in 3 different strengths, such as EQ 5MG BASE, EQ 10MG BASE, 20MG;EQ 10MG BASE, and administered through 3 routes including TABLET;ORAL, TABLET, ORALLY DISINTEGRATING;ORAL, FILM;ORAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 18 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...

watch_later Watch: autorenew Loading watch analysis...

rocket_launch Opportunity: autorenew Loading opportunity analysis...

Country

flag

Legal Status

gavel

Expiry From

calendar_today

Expiry To

calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

✓ Latest exclusivity data and extensions

Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength	Route of Administration	Companies	Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

	Patent Number	Publication Date	Legal Status	Patent Expiry Date
{"application_id":"115018","ingredient":"RIZATRIPTAN BENZOATE","trade_name":"RIZAFILM","family_id":"14ef643db3c24025ab35","publication_number":"US9301948B2","cleaned_patent_number":"9301948","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-07-30","publication_date":"2016-04-05","legal_status":"Granted"}	US9301948B2 Molecular Formulation	05 Apr, 2016	Granted	30 Jul, 2034
{"application_id":"164559","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"","publication_number":"US10058614B2","cleaned_patent_number":"10058614","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2018-08-28","legal_status":"Granted"}	US10058614B2 Formulation	28 Aug, 2018	Granted	11 Apr, 2036
{"application_id":"164503","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10137131B2","cleaned_patent_number":"10137131","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2018-11-27","legal_status":"Granted"}	US10137131B2 Formulation	27 Nov, 2018	Granted	11 Apr, 2036
{"application_id":"164504","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10195278B2","cleaned_patent_number":"10195278","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2019-02-05","legal_status":"Granted"}	US10195278B2	05 Feb, 2019	Granted	11 Apr, 2036
{"application_id":"164506","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10265324B2","cleaned_patent_number":"10265324","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2019-04-23","legal_status":"Granted"}	US10265324B2	23 Apr, 2019	Granted	11 Apr, 2036
{"application_id":"164509","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10363312B2","cleaned_patent_number":"10363312","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2019-07-30","legal_status":"Granted"}	US10363312B2	30 Jul, 2019	Granted	11 Apr, 2036
{"application_id":"164516","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10369224B2","cleaned_patent_number":"10369224","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2019-08-06","legal_status":"Granted"}	US10369224B2	06 Aug, 2019	Granted	11 Apr, 2036
{"application_id":"164519","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10426839B2","cleaned_patent_number":"10426839","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2019-10-01","legal_status":"Granted"}	US10426839B2	01 Oct, 2019	Granted	11 Apr, 2036
{"application_id":"164560","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10463736B2","cleaned_patent_number":"10463736","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2019-11-05","legal_status":"Granted"}	US10463736B2 Formulation	05 Nov, 2019	Granted	11 Apr, 2036
{"application_id":"164520","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10471014B2","cleaned_patent_number":"10471014","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2019-11-12","legal_status":"Granted"}	US10471014B2	12 Nov, 2019	Granted	11 Apr, 2036
{"application_id":"164522","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10471069B2","cleaned_patent_number":"10471069","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2019-11-12","legal_status":"Granted"}	US10471069B2	12 Nov, 2019	Granted	11 Apr, 2036
{"application_id":"164523","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10512692B2","cleaned_patent_number":"10512692","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2019-12-24","legal_status":"Granted"}	US10512692B2	24 Dec, 2019	Granted	11 Apr, 2036
{"application_id":"164525","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10512693B2","cleaned_patent_number":"10512693","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2019-12-24","legal_status":"Granted"}	US10512693B2	24 Dec, 2019	Granted	11 Apr, 2036
{"application_id":"164499","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"","publication_number":"US10517950B1","cleaned_patent_number":"10517950","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2019-12-31","legal_status":"Granted"}	US10517950B2	31 Dec, 2019	Granted	11 Apr, 2036
{"application_id":"164517","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10532101B1","cleaned_patent_number":"10532101","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-01-14","legal_status":"Granted"}	US10532101B2	14 Jan, 2020	Granted	11 Apr, 2036
{"application_id":"164515","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10537642B1","cleaned_patent_number":"10537642","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-01-21","legal_status":"Granted"}	US10537642B2	21 Jan, 2020	Granted	11 Apr, 2036
{"application_id":"164514","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10561664B1","cleaned_patent_number":"10561664","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-02-18","legal_status":"Granted"}	US10561664B2	18 Feb, 2020	Granted	11 Apr, 2036
{"application_id":"164512","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10583144B2","cleaned_patent_number":"10583144","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-03-10","legal_status":"Granted"}	US10583144B2	10 Mar, 2020	Granted	11 Apr, 2036
{"application_id":"164511","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10653777B2","cleaned_patent_number":"10653777","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-05-19","legal_status":"Granted"}	US10653777B2	19 May, 2020	Granted	11 Apr, 2036
{"application_id":"164494","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10688102B2","cleaned_patent_number":"10688102","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-06-23","legal_status":"Granted"}	US10688102B2	23 Jun, 2020	Granted	11 Apr, 2036
{"application_id":"164510","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10688185B2","cleaned_patent_number":"10688185","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-06-23","legal_status":"Granted"}	US10688185B2	23 Jun, 2020	Granted	11 Apr, 2036
{"application_id":"164505","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10695429B2","cleaned_patent_number":"10695429","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-06-30","legal_status":"Granted"}	US10695429B2	30 Jun, 2020	Granted	11 Apr, 2036
{"application_id":"164508","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10695430B2","cleaned_patent_number":"10695430","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-06-30","legal_status":"Granted"}	US10695430B2	30 Jun, 2020	Granted	11 Apr, 2036
{"application_id":"164487","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10702535B2","cleaned_patent_number":"10702535","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-07-07","legal_status":"Granted"}	US10702535B2	07 Jul, 2020	Granted	11 Apr, 2036
{"application_id":"164488","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10702602B2","cleaned_patent_number":"10702602","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-07-07","legal_status":"Granted"}	US10702602B2	07 Jul, 2020	Granted	11 Apr, 2036
{"application_id":"164490","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10722583B2","cleaned_patent_number":"10722583","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-07-28","legal_status":"Granted"}	US10722583B2	28 Jul, 2020	Granted	11 Apr, 2036
{"application_id":"164493","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10729696B2","cleaned_patent_number":"10729696","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-08-04","legal_status":"Granted"}	US10729696B2	04 Aug, 2020	Granted	11 Apr, 2036
{"application_id":"164496","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10729697B2","cleaned_patent_number":"10729697","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-08-04","legal_status":"Granted"}	US10729697B2	04 Aug, 2020	Granted	11 Apr, 2036
{"application_id":"164498","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10729773B2","cleaned_patent_number":"10729773","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-08-04","legal_status":"Patented case"}	US10729773B2	04 Aug, 2020	Patented case	11 Apr, 2036
{"application_id":"164558","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10758617B2","cleaned_patent_number":"10758617","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-09-01","legal_status":"Granted"}	US10758617B2	01 Sep, 2020	Granted	11 Apr, 2036
{"application_id":"164543","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10758618B2","cleaned_patent_number":"10758618","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-09-01","legal_status":"Granted"}	US10758618B2	01 Sep, 2020	Granted	11 Apr, 2036
{"application_id":"164540","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10780165B2","cleaned_patent_number":"10780165","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-09-22","legal_status":"Granted"}	US10780165B2	22 Sep, 2020	Granted	11 Apr, 2036
{"application_id":"164557","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10780166B2","cleaned_patent_number":"10780166","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-09-22","legal_status":"Granted"}	US10780166B2	22 Sep, 2020	Granted	11 Apr, 2036
{"application_id":"164539","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10799588B2","cleaned_patent_number":"10799588","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-10-13","legal_status":"Granted"}	US10799588B2	13 Oct, 2020	Granted	11 Apr, 2036
{"application_id":"164541","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10821181B2","cleaned_patent_number":"10821181","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-11-03","legal_status":"Granted"}	US10821181B2	03 Nov, 2020	Granted	11 Apr, 2036
{"application_id":"164552","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10821182B2","cleaned_patent_number":"10821182","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2020-11-03","legal_status":"Granted"}	US10821182B2	03 Nov, 2020	Granted	11 Apr, 2036
{"application_id":"164550","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10894053B2","cleaned_patent_number":"10894053","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2021-01-19","legal_status":"Granted"}	US10894053B2	19 Jan, 2021	Granted	11 Apr, 2036
{"application_id":"164548","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10905693B2","cleaned_patent_number":"10905693","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2021-02-02","legal_status":"Granted"}	US10905693B2	02 Feb, 2021	Granted	11 Apr, 2036
{"application_id":"164544","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10918722B2","cleaned_patent_number":"10918722","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2021-02-16","legal_status":"Granted"}	US10918722B2	16 Feb, 2021	Granted	11 Apr, 2036
{"application_id":"164537","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10933136B2","cleaned_patent_number":"10933136","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2021-03-02","legal_status":"Granted"}	US10933136B2	02 Mar, 2021	Granted	11 Apr, 2036
{"application_id":"164534","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10933137B2","cleaned_patent_number":"10933137","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2021-03-02","legal_status":"Granted"}	US10933137B2	02 Mar, 2021	Granted	11 Apr, 2036
{"application_id":"164530","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10940153B2","cleaned_patent_number":"10940153","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2021-03-09","legal_status":"Granted"}	US10940153B2	09 Mar, 2021	Granted	11 Apr, 2036
{"application_id":"164492","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US10987358B2","cleaned_patent_number":"10987358","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2021-04-27","legal_status":"Granted"}	US10987358B2	27 Apr, 2021	Granted	11 Apr, 2036
{"application_id":"164546","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11013805B2","cleaned_patent_number":"11013805","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2021-05-25","legal_status":"Granted"}	US11013805B2	25 May, 2021	Granted	11 Apr, 2036
{"application_id":"164489","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11013806B2","cleaned_patent_number":"11013806","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2021-05-25","legal_status":"Granted"}	US11013806B2	25 May, 2021	Granted	11 Apr, 2036
{"application_id":"164528","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11020483B2","cleaned_patent_number":"11020483","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2021-06-01","legal_status":"Granted"}	US11020483B2	01 Jun, 2021	Granted	11 Apr, 2036
{"application_id":"164527","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11045549B2","cleaned_patent_number":"11045549","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2021-06-29","legal_status":"Granted"}	US11045549B2	29 Jun, 2021	Granted	11 Apr, 2036
{"application_id":"164526","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11135295B2","cleaned_patent_number":"11135295","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2021-10-05","legal_status":"Granted"}	US11135295B2	05 Oct, 2021	Granted	11 Apr, 2036
{"application_id":"164524","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11207328B2","cleaned_patent_number":"11207328","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2021-12-28","legal_status":"Granted"}	US11207328B2	28 Dec, 2021	Granted	11 Apr, 2036
{"application_id":"164521","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11219626B2","cleaned_patent_number":"11219626","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2022-01-11","legal_status":"Granted"}	US11219626B2	11 Jan, 2022	Granted	11 Apr, 2036
{"application_id":"164518","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11285213B2","cleaned_patent_number":"11285213","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2022-03-29","legal_status":"Granted"}	US11285213B2	29 Mar, 2022	Granted	11 Apr, 2036
{"application_id":"164513","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11331323B2","cleaned_patent_number":"11331323","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2022-05-17","legal_status":"Granted"}	US11331323B2	17 May, 2022	Granted	11 Apr, 2036
{"application_id":"164507","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11369684B2","cleaned_patent_number":"11369684","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2022-06-28","legal_status":"Granted"}	US11369684B2	28 Jun, 2022	Granted	11 Apr, 2036
{"application_id":"164500","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11426414B2","cleaned_patent_number":"11426414","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2022-08-30","legal_status":"Granted"}	US11426414B2	30 Aug, 2022	Granted	11 Apr, 2036
{"application_id":"164536","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11471464B2","cleaned_patent_number":"11471464","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2022-10-18","legal_status":"Granted"}	US11471464B2	18 Oct, 2022	Granted	11 Apr, 2036
{"application_id":"164556","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11471465B2","cleaned_patent_number":"11471465","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2022-10-18","legal_status":"Granted"}	US11471465B2	18 Oct, 2022	Granted	11 Apr, 2036
{"application_id":"164535","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11504429B2","cleaned_patent_number":"11504429","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2022-11-22","legal_status":"Granted"}	US11504429B2	22 Nov, 2022	Granted	11 Apr, 2036
{"application_id":"164533","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11510927B2","cleaned_patent_number":"11510927","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2022-11-29","legal_status":"Granted"}	US11510927B2	29 Nov, 2022	Granted	11 Apr, 2036
{"application_id":"164555","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11571428B2","cleaned_patent_number":"11571428","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2023-02-07","legal_status":"Granted"}	US11571428B2	07 Feb, 2023	Granted	11 Apr, 2036
{"application_id":"164531","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11602563B2","cleaned_patent_number":"11602563","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2023-03-14","legal_status":"Granted"}	US11602563B2	14 Mar, 2023	Granted	11 Apr, 2036
{"application_id":"164554","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11607456B2","cleaned_patent_number":"11607456","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2023-03-21","legal_status":"Granted"}	US11607456B2	21 Mar, 2023	Granted	11 Apr, 2036
{"application_id":"164497","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11617755B2","cleaned_patent_number":"11617755","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2023-04-04","legal_status":"Granted"}	US11617755B2	04 Apr, 2023	Granted	11 Apr, 2036
{"application_id":"164553","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11617756B2","cleaned_patent_number":"11617756","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2023-04-04","legal_status":"Granted"}	US11617756B2	04 Apr, 2023	Granted	11 Apr, 2036
{"application_id":"164551","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11617791B2","cleaned_patent_number":"11617791","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2023-04-04","legal_status":"Granted"}	US11617791B2	04 Apr, 2023	Granted	11 Apr, 2036
{"application_id":"164549","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11628173B2","cleaned_patent_number":"11628173","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2023-04-18","legal_status":"Granted"}	US11628173B2	18 Apr, 2023	Granted	11 Apr, 2036
{"application_id":"164547","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11712441B2","cleaned_patent_number":"11712441","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2023-08-01","legal_status":"Granted"}	US11712441B2	01 Aug, 2023	Granted	11 Apr, 2036
{"application_id":"164545","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11738085B2","cleaned_patent_number":"11738085","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2023-08-29","legal_status":"Granted"}	US11738085B2	29 Aug, 2023	Granted	11 Apr, 2036
{"application_id":"164542","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11759522B2","cleaned_patent_number":"11759522","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2023-09-19","legal_status":"Granted"}	US11759522B2	19 Sep, 2023	Granted	11 Apr, 2036
{"application_id":"164538","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11801250B2","cleaned_patent_number":"11801250","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2023-10-31","legal_status":"Granted"}	US11801250B2	31 Oct, 2023	Granted	11 Apr, 2036
{"application_id":"164532","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11806354B2","cleaned_patent_number":"11806354","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2023-11-07","legal_status":"Granted"}	US11806354B2	07 Nov, 2023	Granted	11 Apr, 2036
{"application_id":"164529","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11826370B2","cleaned_patent_number":"11826370","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2023-11-28","legal_status":"Patented case"}	US11826370B2	28 Nov, 2023	Patented case	11 Apr, 2036
{"application_id":"164495","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US11865117B2","cleaned_patent_number":"11865117","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2024-01-09","legal_status":"Granted"}	US11865117B2	09 Jan, 2024	Granted	11 Apr, 2036
{"application_id":"164501","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US9821075B2","cleaned_patent_number":"9821075","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2017-11-21","legal_status":"Granted"}	US9821075B2 Formulation	21 Nov, 2017	Granted	11 Apr, 2036
{"application_id":"164502","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"","publication_number":"US10029010B1","cleaned_patent_number":"10029010","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2036-04-11","publication_date":"2018-07-24","legal_status":"Granted"}	US10029010B2	24 Jul, 2018	Granted	11 Apr, 2036
{"application_id":"164491","ingredient":"MELOXICAM; RIZATRIPTAN BENZOATE","trade_name":"SYMBRAVO","family_id":"4a2aea74466a48178405","publication_number":"US12128052B2","cleaned_patent_number":"12128052","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-05-28","publication_date":"2024-10-29","legal_status":"Granted"}	US12128052B2	29 Oct, 2024	Granted	28 May, 2040

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID	Title	Status	Phase	Conditions	Start Date	Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

Filter by Country

View Complete Supplier List

Unlock access to all suppliers of Rizatriptan Benzoate

✓ Access a comprehensive list of global suppliers

✓ Get information on each supplier

Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.